Lot No.3 - reagents for analyzers cobas
c 311, Cobas
Diagnostic company Roche (SIX:RO) (ROG:RHHBY) (OTCQX:RHHBY) reported on Thursday the receipt of US Food and Drug Administration (FDA) 510(k) clearance for the cobas
TV/MG test for use on the cobas
6800/8800 Systems for the detection of Trichomonas vaginalis (TV) and/or Mycoplasma genitalium (MG) DNA.
Through its parent company Santa Comba, Cobas
Asset Management has taken a majority stake in London-based Palm Harbour Capital.
Unstained 5-[micro]m FFPE sections from surgical samples were evaluated for HR-HPV by cobas
, and comparisons were made with DNA ISH and p16 IHC.
"With the addition of the cobas
MRSA/SA Test to our expanding menu of tests for the cobas(r) 4800 System, Roche offers laboratories and clinicians a highly efficient molecular solution to aid in the overall management and prevention of healthcare-associated infections, leading to lower costs for hospitals and optimal patient care."
HPV test uses a sample of cervical cells to detect DNA from 14 high-risk human papillomavirus types.
BRAF Mutation Test is a companion diagnostic developed by Roche to identify patients with melanoma tumors that carry a mutated form of the BRAF gene, and will be eligible for treatment with Zelboraf (vemurafenib), once it is commercially available.
TaqMan assay was performed as per the manufacturer's instructions employing a primer set specific for the M.
Testing for Chlamydia trachomatis and Neisseria gonorrhoeae using the specimen from the ThinPrep Pap test collection vial, using the COBAS
Amplicor automated system (Roche Diagnostics).
The 4000th COBAS
AMPLICOR(TM) Analyser has been manufactured by Roche Diagnostics.
The COBAS[R] Core HEp2 ANA EIA (COBAS-ANA; Roche Diagnostics, Mannheim, Germany), an EIA reagent set for ANA detection, was used to detect ANAs with a COBAS
Core II (Roche Diagnostics), an automated analyzer for EIAs.
Contract notice: rehabilitation of the main runway and creation of two acceleration bands on the cobas